BioCentury
ARTICLE | Clinical News

Viz: Phase IIb data

October 19, 2015 7:00 AM UTC

An open-label Phase IIb trial in 183 patients with fractures of the tibial plateau that required fixation and grafting showed that high-dose KUR-111 met the primary endpoint of non-inferiority to ilia...